Photo collage: Axios Visuals. Photo: Courtesy of Roche
Roche and its biotech unit Genentech are seeking more licensing, collaboration and M&A deals across multiple therapeutic areas, says Roche head of BD Boris Zaïtra.
The big picture: Roche is already managing more than 200 biotech collaborations — and plans to expand further.
